Duoqin Huang
Datos Biográficos
| ID | 7968517 |
|---|---|
| NOMBRE | Duoqin Huang |
| NOMBRES | Duoqin |
| APELLIDO | Huang |
| FIRMA | HUANG D |
| AFILIACIONES | Gannan Medical University |
| ORCID | 0009-0000-5952-7884 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2025 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Post marketing safety assessment of the novel postpartum depression drug, Zuranolone
This study revealed potential AEs of Zuranolone, confirming known safety information about Zuranolone, providing comprehensive data for medical practice and public health decision-making, and laying the foundation for further clinical research. It also provides more comprehensive and updated evidence for the clinical safety of Zuranolone
Sin obras prominentes en esta página.
Post marketing safety assessment of the novel postpartum depression drug, Zuranolone
This study revealed potential AEs of Zuranolone, confirming known safety information about Zuranolone, providing comprehensive data for medical practice and public health decision-making, and laying the foundation for further clinical research. It also provides more comprehensive and updated evidence for the clinical safety of Zuranolone
Adverse effect (1 obras) · Adverse Event Reporting System (1 obras) · Anxiety (1 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 obras) · Maternal Mental Health During Pregnancy and Postpartum (1 obras) · Medicine (1 obras) · Pharmacology (1 obras) · Pharmacovigilance (1 obras) · Pregnancy and Medication Impact (1 obras) · Psychiatry (1 obras)